0001209191-21-036710.txt : 20210528 0001209191-21-036710.hdr.sgml : 20210528 20210528201825 ACCESSION NUMBER: 0001209191-21-036710 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210527 FILED AS OF DATE: 20210528 DATE AS OF CHANGE: 20210528 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PICKERING GRANT CENTRAL INDEX KEY: 0001258693 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39323 FILM NUMBER: 21982461 MAIL ADDRESS: STREET 1: 3005 FIRST AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Vaxcyte, Inc. CENTRAL INDEX KEY: 0001649094 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464233385 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 BUSINESS PHONE: 650-837-0111 MAIL ADDRESS: STREET 1: 353 HATCH DR CITY: FOSTER CITY STATE: CA ZIP: 94404 FORMER COMPANY: FORMER CONFORMED NAME: SutroVax, Inc. DATE OF NAME CHANGE: 20150724 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-05-27 0 0001649094 Vaxcyte, Inc. PCVX 0001258693 PICKERING GRANT C/O VAXCYTE, INC. 353 HATCH DRIVE FOSTER CITY CA 94404 1 1 0 0 Chief Executive Officer Common Stock 2021-05-27 4 M 0 12246 1.79 A 592500 D Common Stock 2021-05-27 4 S 0 12246 22.10 D 580254 D Common Stock 2021-05-28 4 M 0 2656 1.79 A 582910 D Common Stock 2021-05-28 4 S 0 2656 22.16 D 580254 D Common Stock 355660 I By Children's Trusts Stock Option (right to buy) 1.79 2021-05-27 4 M 0 12246 0.00 D 2027-05-17 Common Stock 12246 436569 D Stock Option (right to buy) 1.79 2021-05-28 4 M 0 2656 0.00 D 2027-05-17 Common Stock 2656 433913 D Includes 1,563 shares acquired under the Employee Stock Purchase Plan on May 17, 2021. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.29. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The price reported is a weighted-average price. The shares were sold at prices ranging from $22.00 to $22.405. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. The shares subject to the option are fully vested and exercisable. /s/ Winston Macaraeg, Attorney-in-Fact 2021-05-28